Edmonton has the most comprehensive Canadian psychedelic-assisted therapy landscape — not by accident. Two important features make Edmonton distinctive: ATMA CENA's corporate clinic in Edmonton (one of two ATMA CENA corporate clinics nationwide alongside Calgary) and the Misericordia / Grey Nuns Hospital publicly funded IV ketamine program, Canada's only AHCIP-covered outpatient psychiatric ketamine pathway. Alberta Blue Cross's March 2024 PAT (Psychedelic-Assisted Therapy) coverage added the first formal Canadian private insurance pathway for ketamine-assisted therapy. CPSA's regulatory framework — including the Ketamine Clinical Toolkit and Non-Hospital Surgical Facility (NSHF) accreditation requirements — provides operational clarity for Edmonton clinics. Psilocybin and MDMA SAP-pathway access operates through standard Health Canada framework with ATMA CENA supporting preparation and integration through our care coordination model. This article walks through the full Edmonton landscape across ketamine, Spravato, psilocybin SAP, MDMA SAP, training, and insurance.
Key takeaways
- ATMA CENA's Edmonton corporate clinic delivers KAT (ketamine-assisted therapy) primarily through IM and SL ketamine. One of two ATMA CENA corporate clinics nationwide.
- Misericordia / Grey Nuns IV ketamine program (Covenant Health) — Canada's only AHCIP-covered outpatient psychiatric ketamine pathway. Ultra-resistant TRD with psychiatric referral.
- Alberta Blue Cross PAT coverage (March 2024) — first Canadian insurer to formally cover psychedelic-assisted therapy. ATMA CENA was a partner in the announcement.
- CPSA regulatory framework: Ketamine Clinical Toolkit; NSHF accreditation for IV ketamine; broader psychedelic-assisted therapy guidance.
- Psilocybin and MDMA SAP-pathway access: standard Health Canada framework. ATMA CENA supports preparation and integration via coordinated care.
- Spravato pathway: private prior auth (PSHCP for federal public servants; Manulife/Sun Life/Green Shield/Blue Cross for others); Janssen Journey-certified providers in Edmonton.
- Veterans: VAC ketamine coverage is established; MDMA-AT case-by-case for service-related PTSD.
What Edmonton offers across psychedelic-assisted therapy
Edmonton's substance-by-substance landscape:
Ketamine therapy
The most-developed Edmonton pathway. Multiple options:
-
ATMA CENA Edmonton corporate clinic — KAT via IM and SL ketamine; three-phase model (preparation, dosing, integration); ATMA CENA's published KAT pricing tiers apply (CAD $1,530–$6,930 per program). For modality detail, see Ketamine Therapy in Edmonton (city spoke deep dive).
-
Misericordia / Grey Nuns publicly funded IV ketamine program — Covenant Health-operated; AHCIP coverage for ultra-resistant TRD with psychiatric referral. Mon–Fri 6:30 AM–2:30 PM service. The only Canadian publicly funded outpatient psychiatric ketamine pathway. See Edmonton Misericordia/Grey Nuns Public Ketamine Program.
-
SABI Mind Edmonton — IV ketamine clinic with anesthesiology medical leadership; part of multi-clinic SABI network.
-
The Linden Medical Centre Edmonton — IV ketamine; led by Dr. Monika Hooper psychiatrist.
-
Other Edmonton ketamine providers including Field Trip Health locations and other private clinics.
Spravato (intranasal esketamine)
Spravato is Health Canada-approved for treatment-resistant MDD and is the most likely-covered psychedelic-assisted therapy product through private insurance prior auth. Edmonton Spravato providers operate as Janssen Journey-certified clinics, with mandatory ≥2-hour observation post-dose. For coverage detail: PSHCP / Canada Life Spravato Coverage (federal public servants), Private Insurance Prior Authorization for Spravato (Manulife/Sun Life/Green Shield/Blue Cross).
Psilocybin (SAP-pathway only)
Psilocybin in Edmonton is accessible via Health Canada Special Access Program (SAP) only — no Health Canada approved indication, no off-label legal pathway. The SAP application is initiated by the patient's prescribing physician for serious or life-threatening conditions where conventional treatments have failed. ATMA CENA supports preparation and integration via coordinated care in coordination with the prescribing physician.
For Edmonton SAP-pathway psilocybin: TheraPsil-trained Alberta clinicians, ATMA CENA's three-phase preparation/integration support, and SAP authorization through the prescribing physician. Filament Health often supplies SAP-approved psilocybin at no charge — meaningful Canadian-specific cost reduction.
For further reading: Psilocybin Therapy in Canada, How to Access Psilocybin Therapy in Canada.
MDMA-AT (SAP-pathway only)
MDMA-assisted therapy in Edmonton operates under the same SAP framework as psilocybin. The dominant indication is service-related PTSD, drawing on Mitchell 2021/2023 Nature Medicine Phase 3 evidence. Veterans Affairs Canada considers MDMA-AT case-by-case for service-related PTSD where SAP-approved.
For further reading: MDMA-Assisted Therapy in Canada, MDMA-Assisted Therapy for Veterans.
Training and clinical pathways
ATMA CENA's psychedelic-assisted therapy training program operates from Edmonton with cross-country reach. The training prepares clinicians (physicians, psychotherapists, registered psychologists) for psychedelic-assisted therapy work consistent with CPSA framework. See Psychedelic Therapy Training in Canada.
ATMA CENA's Edmonton corporate clinic
ATMA CENA's Edmonton corporate clinic is one of two ATMA CENA corporate clinics nationwide (alongside Calgary). Key features:
- Three-phase psychedelic-assisted therapy model: preparation + dosing + integration
- Primary delivery: IM and SL ketamine (off-label psychiatric)
- Pricing tiers: KAT Psychedelic Pathway $1,585 + $795/additional; KAT Psycholytic Pathway $1,530 + $740/additional; Customized $2,325–$6,930
- Coordinated care: your existing therapist remains primary while ATMA CENA's clinical infrastructure provides medical oversight and dosing
Edmonton's ketamine options are covered in depth in our Edmonton ketamine therapy guide.
Edmonton's regulatory framework
Three layers govern Edmonton psychedelic-assisted therapy:
Federal — Health Canada and CDSA
- Ketamine: Schedule I CDSA; Health Canada approved as anaesthetic; psychiatric off-label use is legal standard practice
- Spravato: Health Canada approved for TRD May 2020; Janssen Journey controlled distribution
- Psilocybin: Schedule III CDSA; no approved indication; SAP-only access since January 5, 2022
- MDMA: Schedule I CDSA; no approved indication; SAP-only access since January 5, 2022
Provincial — CPSA Alberta
CPSA's framework includes:
- Ketamine Clinical Toolkit — guidance for Alberta clinicians
- Non-Hospital Surgical Facility (NSHF) accreditation — required for IV ketamine in non-hospital settings under Off-label IV Sedative/Anaesthetic Standards
- Psychedelic-assisted therapy guidance — applicable to ATMA CENA's corporate clinic and other Alberta KAT operations
- March 2026 Ketamine Prescribing Guidance — most current CPSA position
For the broader regulatory context: Is Ketamine Therapy Legal in Canada?, Is Psilocybin Legal in Canada?, Is MDMA Therapy Legal in Canada?.
Insurance / coverage
Edmonton's Alberta-province coverage architecture:
- AHCIP: covers Misericordia/Grey Nuns IV ketamine program for ultra-resistant TRD
- Alberta Blue Cross PAT (March 2024): covers ketamine-assisted therapy under group, workplace, individual plans. Confirm current 2026 scope including any potential expansion to psilocybin or MDMA. See Alberta Blue Cross PAT Coverage.
- PSHCP / Canada Life: Spravato coverage for federal public servants via Form M7520. See PSHCP / Canada Life Spravato Coverage.
- Private insurance: Spravato most likely covered with prior auth; off-label ketamine generally not covered.
- VAC: veterans with service-related conditions — established ketamine coverage; MDMA case-by-case for PTSD; psilocybin not covered. See VAC Coverage for Psychedelic-Assisted Therapy.
- WCB Alberta: ketamine for compensable CRPS, refractory neuropathic pain, presumptive PTSD for first responders under Bill 27.
For an overview of all coverage options: Insurance Coverage for Psychedelic-Assisted Therapy in Canada.
Local Edmonton practical notes
- Population: Edmonton CMA ~1.5M (Alberta's capital and second-largest city)
- Major hospitals: University of Alberta Hospital (Royal Alexandra), Misericordia Community Hospital (Covenant Health, IV ketamine program), Grey Nuns Community Hospital (Covenant Health, IV ketamine program)
- Universities: University of Alberta; MacEwan University
- Health authority: Alberta Health Services
- Transit: Edmonton Transit Service (ETS); Edmonton LRT
- Major industries: government (provincial capital), petroleum, healthcare, education
- Catchment: Edmonton, Sherwood Park, St. Albert, Spruce Grove; northern Alberta referrals
- Post-session: 24-hour no-driving rule across all psychedelic modalities; ETS and rideshare practical alternatives
How to start
The realistic Edmonton pathway:
- Identify your indication and treatment history. TRD? PTSD? Anxiety? Chronic pain? End-of-life distress?
- Map to substance pathway: ketamine (broadly accessible); Spravato (Health Canada approved for TRD); psilocybin SAP (best evidence end-of-life); MDMA-AT SAP (best evidence PTSD).
- Map to coverage pathway: Alberta Blue Cross PAT, AHCIP Misericordia/Grey Nuns, PSHCP, VAC, WCB Alberta, or out-of-pocket.
Frequently asked questions
Where is ATMA CENA's Edmonton corporate clinic? ATMA CENA Edmonton — one of two ATMA CENA corporate clinics nationwide. Confirm specific address through ATMA CENA intake call.
What does ATMA CENA offer in Edmonton? KAT (ketamine-assisted therapy) primarily through IM and SL ketamine, three-phase psychedelic-assisted therapy model, preparation and integration support for SAP-pathway psilocybin and MDMA via coordinated care, training program for Canadian clinicians.
Can I access publicly funded ketamine in Edmonton? Yes — through the Misericordia/Grey Nuns IV ketamine program (Covenant Health, AHCIP-covered). Eligibility: ultra-resistant TRD with psychiatric referral. Cannot self-refer.
Does Alberta Blue Cross cover ketamine therapy? Yes through the March 2024 PAT coverage launch — for ketamine-assisted therapy under group, workplace, and individual plans. Psilocybin and MDMA framed as future potential.
Is psilocybin therapy available in Edmonton? Through Health Canada SAP only. The medical SAP application is initiated by the patient's prescribing physician. ATMA CENA supports preparation and integration via coordinated care.
Is MDMA-AT available in Edmonton? Through Health Canada SAP only. Veterans with service-related PTSD have the most established VAC pathway. ATMA CENA supports preparation and integration via coordinated care.
What about Spravato in Edmonton? Available through Janssen Journey-certified providers including Edmonton hospital affiliates. Most likely-covered through private insurance prior auth.
Does ATMA CENA offer training in Edmonton? Yes — ATMA CENA's psychedelic-assisted therapy training program operates with Edmonton as one base. See Psychedelic Therapy Training in Canada.
What about Calgary patients? ATMA CENA also operates a corporate clinic in Calgary. See Psychedelic-Assisted Therapy in Calgary.
Is there a Canadian-only outpatient publicly funded ketamine program? The Misericordia/Grey Nuns Edmonton program is Canada's only publicly funded outpatient psychiatric IV ketamine pathway. Other Canadian ketamine work is private-pay or insurance-covered.
Sources
- ATMA CENA — find care near you: https://psychedelic.healthcare/find-care
- Covenant Health — Ketamine for Depression: https://covenanthealth.ca/news-and-events/news/ketamine-used-to-treat-depression-at-the-misericordia-and-grey-nuns-hospitals
- CPSA — Ketamine Clinical Toolkit: https://cpsa.ca/resources/ketamine-toolkit/
- Alberta Blue Cross / ATMA CENA announcement (March 2024): https://www.atmajourney.com/alberta-blue-cross-covers-pat/
- Health Canada DPD — Spravato: https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98903
- Health Canada — SAP psychedelic-assisted psychotherapy: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/requests-special-access-program-psychedelic-assisted-psychotherapy.html
- Veterans Affairs Canada — Mental Health Benefits: https://www.veterans.gc.ca/en/financial-programs-and-services/medical-costs/coverage-services-prescriptions-and-devices/mental-health-benefits
- WCB Alberta — Pharmaceutical Ketamine and Esketamine: https://www.wcb.ab.ca/about-wcb/procedures-manual/pharmaceutical-ketamine-and-esketamine.html
- Alberta Health Services: https://www.albertahealthservices.ca/
- Anand A, et al. (2023). Ketamine versus ECT for nonpsychotic TRD: ELEKT-D. NEJM. https://pubmed.ncbi.nlm.nih.gov/37224135/
- TheraPsil: https://therapsil.ca/
Related articles
- Ketamine Therapy in Edmonton
- Edmonton Misericordia/Grey Nuns Public Ketamine Program
- Alberta Blue Cross PAT Coverage
- Insurance Coverage for Psychedelic-Assisted Therapy in Canada
- Psilocybin Therapy in Canada
- MDMA-Assisted Therapy in Canada
- Ketamine Therapy in Canada
- Psychedelic Therapy Training in Canada
- Find care near you
- Psychedelic-Assisted Therapy in Calgary
Last updated: 2026-05-06